Alcon supports serious research in eye health and works to expand the frontiers of ophthalmic and optometric sciences through the Alcon Research Institute (ARI).
Since its inception in 1981, the ARI has granted almost $21 million to more than 234 researchers in support of their research into eye disease and ophthalmology. According to a recently completed survey of the ARI membership, there is general consensus that the ARI has been successful in having a strong impact on the state of eye research in the world. The value of the unrestricted nature of these awards cannot be overestimated. It gives the awardee great freedom of choice with regard to the area of ocular research to pursue, including the option of starting a new direction and bringing in new technology. The survey also revealed that 93 percent of the ARI awards were leveraged to obtain additional funding from various agencies and almost half percent of that funding was for new directions in ocular diseases. As a result, almost 80 percent of ARI recipients have indicated that their award had a major impact on their research.
During the past 28 years the Association for Research in Vision and Ophthalmology (ARVO) has bestowed over 125 major awards; 47 percent of those were also ARI recipients, an indication of the prestige of the scientists chosen by the ARI Scientific Selection Committee (SSC). It is also quite significant that about 50 percent of those chosen as ARI winners were in advance of an ARVO award – that is, they were recognized as significant contributors to vision research by the ARI before ARVO recognized them as such.